Top Medical News

Neurofilament Light Shows Utility as Independent Biomarker for Disease Worsening in MS

June 30, 2022

By Marco Meglio

Patients with high levels of neurofilament light at baseline had an increased risk of developing new T2 lesions and of experiencing a new clinical relapse in the follow-up period, but not of EDSS progression.

AHS 2022: Top Interviews and Key Takeaways

June 29, 2022

By Matt Hoffman

The NeurologyLive® team assembled some of the best discussions with leaders in headache and migraine medicine following the 2022 American Headache Society (AHS) Annual Scientific Meeting.

ALS-Related Biomarkers Remain Unchanged With PrimeC Combination Treatment

June 29, 2022

By Marco Meglio

Following positive phase 2a findings, NeuroSense’s agent PrimeC continued to show a mechanistic impact on biomarkers specific to patients with amyotrophic lateral sclerosis.

Pioneering Care for Autoimmune Disorders Through Research and Results: The Mayo Clinic Way

June 29, 2022

By Marco Meglio

Through dedicated research into biomarker discovery and patient care, the neuroimmunology laboratory at Mayo Clinic has paved a new way of life for those with autoimmune disorders.

NeuroVoices: Heidi Schambra, MD, on Expanding Capabilities of Stroke Rehabilitation With the PrimSeq Digital Tool

June 29, 2022

By Marco Meglio

The associate professor in the Department of Rehabilitation Medicine at NYU Langone discussed a recent study on a new tool aimed at quantifying movements during stroke rehabilitation.

Featured


Latest Videos


Most Recent